Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. (New England journal of medicine, 2005)

(untitled) - Keymeulen, B; Vandemeulebroucke, E; Ziegler, A; Mathieu, C; Kaufman, L; Hale, G; Gorus, F; Goldman, M; Walter, M; Candon, S; Schandene, L; Crenier, L; et al.